Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location: Home > Pharma China Web Edition > Product/R&D News    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905
Email:
info@pharmachinaonline.com

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Email:
info@pharmachinaonline.com
 
 
 
Product/R&D News
 
CBT Pharma Initiates the APOLLO Oncology Clinical Trials Program 9/18/2018
EpimAb Announces IND Filing for EMB01 in China and the US 9/14/2018
Chinese Drug-releasing Heart Stent Clears Clinical Trials in Euro... 9/14/2018
Innovent Receives Chinese IND Approval for mAb Drug Candidate 9/11/2018
Luye Pharma's Prostate Cancer Drug Initiates Phase III Clinical T... 9/7/2018
Minomic Secures Key Patent in the U.S. and China 9/5/2018
NYT: China Withholds H7N9 Bird Flu Sample 8/30/2018
CStone's Anti-CTLA-4 Antibody CS1002 Receives IND Approval in Chi... 8/29/2018
I-Mab Approved to Initiate Clinical Study of Genexine’s Diabetes... 8/28/2018
BeiGene Announces CNDA Acceptance of its First NDA for Zanubrutin... 8/28/2018
USFDA Approves IND of Frontier Biotech's Novel Long-acting, All-i... 8/24/2018
Zai Lab's ZL-2306 (niraparib) Completes PK Study in Chinese Ovari... 8/21/2018
Bio-Thera Announces CNDA Acceptance of Biologics Application for ... (free) 8/20/2018
CANbridge Approved to Commence CAN017 Ib/III Trial for ESCC in Ch... (free) 8/14/2018
Sihuan Pharma's Self-Developed Anticancer Pirotinib Commenced Pha... (free) 8/14/2018
CBT Pharma Gets Ethics Approval for APOLLO-1 Phase 1/2 Trial for ... (free) 8/8/2018
MorphoSys and I-Mab Announce China IND Submission of mAb for MM 8/7/2018
Nobel Laureate to Launch Biomedicine Laboratory in Shenzhen 8/3/2018
Clover Biopharma Initiates Phase I Study of Etanercept Biosimilar... (free) 8/2/2018
Bio-Thera Initiates Phase I Trial for Biosimilar of Actemra (Toci... (free) 7/27/2018
CBT Pharma Initiates Phase 1b Trial for Anti-PD-1 Antibody Drug 7/26/2018
BeiGene Reports Progress of Pivotal Trial for Anti-PD-1 Antibody ... 7/24/2018
Xinhua: China's New Drug for Alzheimer's Completes Phase 3 Trial 7/17/2018
Sirona Biochem Announces CNDA Approval of SGLT2 Inhibitor for Pha... 7/12/2018
CStone's PD-1 Inhibitor CS1003 Gets Clinical Trial Approval in Ch... 7/12/2018
China Close to Approve Fruquintinib for Colon Cancer 7/3/2018
Luye Pharma's Class 1.1 New Analgesic to Start Phase I Trial in C... 6/20/2018
Pharnext's Orphan Drug PXT3003 Granted Priority Review in China 6/14/2018
CStone Initiates Two Pivotal Phase II Studies of Anti-PD-L1 mAb C... 6/13/2018
China Approves 4-Strain Flu Vaccine for 2018 (free) 6/12/2018
Page:1/4    Total number of articles:96  :[1][2][3][4]

 
 
 
 
© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links